APIs & Intermediates Suppliers & Product for Paris

Your Trusted Strategic Partner for High-Quality Pharmaceutical Ingredients and Advanced Intermediates in the Heart of Europe’s Biotech Hub.

Send Inquiry Now

Paris: The Epicenter of European Pharmaceutical R&D

Paris is not only the cultural capital of the world but also a dominant force in the global pharmaceutical and life sciences industry. With the presence of the Genopole biocluster and the Paris-Saclay innovation hub, the demand for high-purity Active Pharmaceutical Ingredients (APIs) and chemical intermediates has reached unprecedented levels. As a leading supplier from China, Jiangxi Serum Pharma Industries Co., Ltd. bridges the gap between Asian manufacturing prowess and Parisian excellence.

The local industrial landscape in the Île-de-France region is characterized by a sophisticated network of multinational giants (like Sanofi), burgeoning biotech startups, and world-class research hospitals (AP-HP). Our role as a global APIs & Intermediates supplier is to provide the critical molecular building blocks that drive these innovations forward.

Paris Lab Innovation
500+

Long-term Global Clients

200+

Certified Suppliers

$10M+

Annual Sales Excellence

10yr

Industry Experience

🛡️ Localized Support & Compliance for French Enterprises

Navigating the regulatory environment in France requires more than just high-quality products; it requires an understanding of ANSM (National Agency for the Safety of Medicines and Health Products) and EMA (European Medicines Agency) standards. Our supply chain is built on the pillars of transparency and traceability, ensuring that every batch of API or intermediate delivered to Paris meets stringent European pharmacopoeia requirements.

We provide comprehensive documentation support, including DMF (Drug Master Files), CEP (Certificate of Suitability), and GMP (Good Manufacturing Practice) certifications. This localized approach reduces the regulatory burden on French manufacturers and accelerates the "time-to-market" for new therapeutic solutions.

Furthermore, our logistics network is optimized for the French market. By leveraging major European ports and the Charles de Gaulle (CDG) airport logistics hub, we ensure temperature-controlled, rapid delivery of sensitive biological materials and pharmaceutical ingredients directly to Paris-based laboratories.

Get Compliance Documents

⚙️ The China Advantage: Cost-Efficiency Meets Innovation

Scale of Economy

Our Jiangxi-based facilities leverage China's massive industrial infrastructure to provide competitive pricing without compromising on 99%+ purity levels.

R&D Integration

We don’t just manufacture; we innovate. Our team specializes in Bio-Fermentation, Pre-mix, and Co-Crystallization technologies to provide customized molecular structures.

Sustainability

Following modern green chemistry principles, we focus on plant-derived alternatives, such as Plant-derived Squalene and plant-based proteins, catering to the "Green Paris" initiatives.

Customization

From small-scale R&D batches to multi-ton commercial production, our factory supports the entire lifecycle of a pharmaceutical product in Paris.

🧪 Development Trends & Paris Application Scenarios

The pharmaceutical industry in Paris is shifting towards Preventative Medicine and Nutraceutical Integration. We are seeing a significant rise in the application of:

  • Anti-Aging Therapeutics: Utilizing high-purity NMN (Nicotinamide Mononucleotide) for longevity clinics in the Paris region.
  • Metabolic Health: The surge in GLP-1 pathway drugs and their intermediates for weight management solutions.
  • Plant-Based Biologics: Transitioning from animal-derived to high-quality Pea and Mung Bean Peptides for hypoallergenic supplements.
  • Essential Oil Pharmacopoeia: Pharmaceutical-grade Eucalyptus and Cinnamon oils for respiratory health products sold in Parisian pharmacies.

Enterprise News: Keeping Paris Informed

Serum Pharma continuously monitors cutting-edge markets. Our latest breakthroughs include the 50-day rapid FDA approval process for oral small-molecule GLP-1 weight-loss drugs, a development that is set to revolutionize the metabolic health market in France and beyond.

News

"Breakthrough! Weight loss becomes increasingly simple: Lilly's oral small-molecule GLP1 drug approved with 50-day rapid process, setting a record for NME approval."

Frequently Asked Questions (FAQ)

What are your lead times for API delivery to Paris? +
For stocked items, air freight to CDG airport typically takes 5-7 business days. For custom synthesis, lead times vary based on molecular complexity but generally range from 4 to 8 weeks.
Do your products comply with European Pharmacopoeia (Ph. Eur.) standards? +
Yes, all our pharmaceutical-grade APIs and intermediates are manufactured to meet or exceed Ph. Eur. or USP standards, accompanied by full COA and GMP documentation.
How does Jiangxi Serum Pharma handle French customs and VAT? +
We work with experienced logistics partners in France to handle DDP (Delivered Duty Paid) shipments if required, ensuring a seamless customs process and proper VAT handling for EU entities.
Can you provide small-scale samples for R&D labs in the Genopole cluster? +
Absolutely. We support the Parisian innovation ecosystem by providing lab-scale samples for feasibility studies and pilot testing.

🏢 About Jiangxi Serum Pharma

Established in 2017, Jiangxi Serum Pharma Industries Co., Ltd. has grown into a titan of the export industry, specializing in vaccines, Western medicines, and high-end plant extracts. With annual sales exceeding $10,000,000 USD, we have proven our reliability and expertise on the global stage. Our commitment to Paris and the wider French market is reflected in our dedicated compliance team and localized logistical solutions.

Headquarters: Jiangxi, China

Experience: 10+ Years in Biological Products & APIs

Network: 200+ Suppliers, 500+ Global Clients

Market Focus: Pharmaceutical, Nutritional, & Cosmetic Intermediates